Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Argenta Discovery announces collaboration with Antisoma
January 2008
by David Hutton  |  Email the author
SHARING OPTIONS:

LONDON—Argenta Discovery Ltd., the pharmaceutical R&D group, announced that it entered into a fee-for-service collaboration with Antisoma plc. Under the terms of the agreement, scientists from the two organizations will work together to develop improved molecules for Antisoma's program of telomere targeting agents (TTAs). Antisoma will utilize Argenta's expertise in medicinal chemistry, computer-aided drug design, molecular biology, biochemistry, assay development and in vitro screening, during the course of the collaboration.

"Antisoma's decision to work with us confirms our contract research team's experience in undertaking integrated, oncology-focused programs, and underlines Argenta's ongoing commitment to providing first-class contract R&D services to leading organizations in the pharmaceutical industry," says Dr. Christopher Ashton, Argenta's CEO.
Medivir, Presidio amend license agreement
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.